{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,21]],"date-time":"2026-08-21T12:40:21Z","timestamp":1787316021101,"version":"build-2736575974"},"reference-count":27,"publisher":"MDPI AG","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001691","name":"Japan Society for the Promotion of Science","doi-asserted-by":"publisher","award":["15K15453"],"award-info":[{"award-number":["15K15453"]}],"id":[{"id":"10.13039\/501100001691","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Diagnostics"],"abstract":"<jats:p>To clarify the differences in hemodynamic status between atherosclerotic steno-occlusive lesions (SOL) and moyamoaya disease (MMD), hemodynamic parameters were compared using 15O-PET. Twenty-four patients with unilateral SOL (67 \u00b1 11 y) and eighteen with MMD (33 \u00b1 16 y) were assigned to this study. MMD patients were divided into twelve unilateral and six bilateral lesions. All patients underwent 15O-PET to measure cerebral blood flow (CBF), blood volume (CBV), oxygen extraction fraction (OEF), and metabolic rate (CMRO2). Acetazolamide was administered after the baseline scan and the second 15O-water PET was performed to evaluate cerebrovascular reactivity (CVR). For the CBF calculation in 15O-water PET, the three-weighted integral method was applied based on a one-tissue compartment model with pixel-by-pixel delay correction to measure precise CBF and arterial-to-capillary blood volume (V0). Baseline hemodynamic parameters showed significantly lower CBF, V0, and CMRO2, but greater CBV, OEF, and delay (p &lt; 0.01) in the affected hemispheres than in the unaffected hemispheres. After ACZ administration, both hemispheres showed a significant increase in CBF (p &lt; 0.0001), but not in V0. CVR differed significantly between the hemispheres. The arterial perfusion pressure of the functioning arterial part tended to be reduced after acetazolamide administration in patients with past neurologic events caused by hemodynamic impairment. MMD patients showed greater inactive vascular and venous volumes compared with common atherosclerotic SOL patients. The hemodynamic status of cerebral circulation may vary according to the chronic process of steno-occlusive change and the development of collateral circulation. In order to evaluate physiologic differences between the two diseases, 15O-PET with an acetazolamide challenge test is useful.<\/jats:p>","DOI":"10.3390\/diagnostics11101820","type":"journal-article","created":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T10:55:40Z","timestamp":1633085740000},"page":"1820","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":6,"title":["Differences in Hemodynamic Alteration between Atherosclerotic Occlusive Lesions and Moyamoya Disease: A Quantitative 15O-PET Study"],"prefix":"10.3390","volume":"11","author":[{"given":"Chiaki","family":"Igarashi","sequence":"first","affiliation":[{"name":"Department of Neurosurgery, Faculty of Medical Sciences, University of Fukui, Eiheiji-cho 910-1193, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7046-3383","authenticated-orcid":false,"given":"Hidehiko","family":"Okazawa","sequence":"additional","affiliation":[{"name":"Biomedical Imaging Research Center, University of Fukui, Eiheiji-cho 910-1193, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2482-6304","authenticated-orcid":false,"given":"Muhammad M.","family":"Islam","sequence":"additional","affiliation":[{"name":"Biomedical Imaging Research Center, University of Fukui, Eiheiji-cho 910-1193, Japan"},{"name":"Department of Biomedical Engineering, Khulna University of Engineering & Technology, Khulna 9203, Bangladesh"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8980-1044","authenticated-orcid":false,"given":"Tetsuya","family":"Tsujikawa","sequence":"additional","affiliation":[{"name":"Biomedical Imaging Research Center, University of Fukui, Eiheiji-cho 910-1193, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshifumi","family":"Higashino","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Faculty of Medical Sciences, University of Fukui, Eiheiji-cho 910-1193, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5598-050X","authenticated-orcid":false,"given":"Makoto","family":"Isozaki","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Faculty of Medical Sciences, University of Fukui, Eiheiji-cho 910-1193, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken-ichiro","family":"Kikuta","sequence":"additional","affiliation":[{"name":"Department of Neurosurgery, Faculty of Medical Sciences, University of Fukui, Eiheiji-cho 910-1193, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,1]]},"reference":[{"key":"ref_1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s11936-003-0039-3","article-title":"Atherosclerotic carotid artery occlusion","volume":"5","author":"Powers","year":"2003","journal-title":"Curr. Treat Options Cardiovasc. Med."},{"key":"ref_2","doi-asserted-by":"crossref","first-page":"e349","DOI":"10.1161\/01.STR.0000135024.54608.3f","article-title":"Population-based study of symptomatic internalcarotid artery occlusion: Incidence and long-term follow-up","volume":"35","author":"Flaherty","year":"2004","journal-title":"Stroke"},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1159\/000439179","article-title":"Asymptomatic caritid stenosis: Risk of progression and development of symptoms","volume":"40","author":"Singh","year":"2015","journal-title":"Cerebrovasc. Dis."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.wneu.2020.05.082","article-title":"A Rare Case of Postinfectious Moyamoya Syndrome: Case Report and Review of the Literature","volume":"140","author":"Trombatore","year":"2020","journal-title":"World Neurosurg."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1161\/STROKEAHA.106.478297","article-title":"Radiological findings, clinical course, and outcome in asymptomatic moyamoya disease: Results of multicenter survey in Japan","volume":"38","author":"Kuroda","year":"2007","journal-title":"Stroke"},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.3171\/2013.10.FOCUS13427","article-title":"Extracranial-intracranial bypass for ischemic cerebrovascular disease: What have we learned from the Carotid Occlusion Surgery Study?","volume":"36","author":"Reynolds","year":"2014","journal-title":"Neurosurg. Focus"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7326\/0003-4819-106-1-27","article-title":"The effect of hemodynamically significant carotid artery disease on the hemodynamic status of the cerebral circulation","volume":"106","author":"Powers","year":"1987","journal-title":"Ann. Intern. Med."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1161\/01.STR.12.4.454","article-title":"Reversal of focal \u201cmisery-perfusion syndrome\u201d by extra-intracranial arterial bypass in hemodynamic cerebral ischemia. A case study with 15O positron emission tomography","volume":"12","author":"Baron","year":"1981","journal-title":"Stroke"},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"E5","DOI":"10.3171\/2009.1.FOCUS08300","article-title":"Quantitative hemodynamic studies in moyamoya disease: A review","volume":"26","author":"Lee","year":"2009","journal-title":"Neurosurg. Focus"},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cpet.2009.12.007","article-title":"PET in Cerebrovascular disease PET","volume":"5","author":"Powers","year":"2010","journal-title":"PET Clin."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s12149-009-0235-7","article-title":"Clinical impact of hemodynamic parameter measurement for cerebrovascular disease using positron emission tomography and 15O-labeled tracers","volume":"23","author":"Okazawa","year":"2009","journal-title":"Ann. Nucl. Med."},{"key":"ref_12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1097\/00004647-199609000-00002","article-title":"Cerebral [15O]water clearance in humans determined by PET: I. Theory and normal values","volume":"16","author":"Ohta","year":"1996","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12149-017-1156-5","article-title":"Pixel-by-pixel precise delay correction for mesuament of cerebral hemodynamic parameters in H215O PET study","volume":"31","author":"Islam","year":"2017","journal-title":"Ann. Nucl. Med."},{"key":"ref_14","first-page":"1398","article-title":"Performance characteristics of a whole-body PET scanner","volume":"35","author":"Turkington","year":"1994","journal-title":"J. Nucl. Med."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1097\/00004647-200107000-00004","article-title":"Quantitative comparison of the bolus and steady-state methods for measurement of cerebral perfusion and oxygen metabolism: Positron emission tomography study using 15O-gas and water","volume":"21","author":"Okazawa","year":"2001","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_16","first-page":"177","article-title":"Brain oxygen utilization measured with O-15 radiotracers and positron emission tomography","volume":"25","author":"Mintun","year":"1984","journal-title":"J. Nucl. Med."},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s00259-006-0192-5","article-title":"Can the detection of misery perfusion in chronic cerebro- vascular disease be based on reductions in baseline CBF and vasoreactivity?","volume":"34","author":"Okazawa","year":"2007","journal-title":"Eur. J. Nucl. Med. Mol. Imaging"},{"key":"ref_18","unstructured":"Myers, R., Cunningham, V., Bailey, D., and Jones, T. (1996). Dispersion correction for automatic sampling of O-15-labeled H2O and red blood cells. Quantification of Brain Function Using PET, Academic Press."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1097\/00004647-200112000-00012","article-title":"Effects of acetazolamide on cerebral blood flow, blood volume and oxygen metabolism: A PET study with healthy volunteers","volume":"21","author":"Okazawa","year":"2001","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_20","first-page":"1069","article-title":"Simultaneous correction for tracer arrival delay and dispersion in CBF measurements by the H215O autoradiographic method and dynamic PET","volume":"30","author":"Meyer","year":"1989","journal-title":"J. Nucl. Med."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1038\/jcbfm.1986.99","article-title":"Error analysis of a quantitative cerebral blood flow measurement using H2O autoradiography and positron emission tomography, with respect to the dispersion of the input function","volume":"6","author":"Iida","year":"1986","journal-title":"J. Cereb. Blood Flow Metab."},{"key":"ref_22","first-page":"33","article-title":"Oxygen extraction fraction and acetazolamide reactivity in symptomatic carotid artery disease","volume":"75","author":"Yamauchi","year":"2004","journal-title":"J. Neurol. Neurosurg. Psychiatry"},{"key":"ref_23","first-page":"1875","article-title":"Relationship between vasodilatation and cerebral blood flow increase in impaired hemodynamics: A PET study with the acetazolamide test in cerebrovascular disease","volume":"44","author":"Okazawa","year":"2003","journal-title":"J. Nucl. Med."},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1056\/NEJMra0804622","article-title":"Moyamoya disease and moyamoya syndrome","volume":"360","author":"Scott","year":"2009","journal-title":"N. Engl. J. Med."},{"key":"ref_25","first-page":"1371","article-title":"Differences of vasodilatory capacity and changes in cerebral blood flow induced by acetazolamide in patients with cerebrovascular disease","volume":"44","author":"Okazawa","year":"2003","journal-title":"J. Nucl. Med."},{"key":"ref_26","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.2967\/jnumed.108.054379","article-title":"Combination of a mean transit time measurement with an acetazolamide test increases predictive power to identify elevated oxygen extraction fraction in occlusive carotid artery diseases","volume":"49","author":"Hokari","year":"2008","journal-title":"J. Nucl. Med."},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1093\/brain\/aws131","article-title":"Is misery perfusion still a predictor of stroke in symptomatic major cerebral artery disease?","volume":"135","author":"Yamauchi","year":"2012","journal-title":"Brain"}],"container-title":["Diagnostics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/2075-4418\/11\/10\/1820\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:08:25Z","timestamp":1760166505000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/2075-4418\/11\/10\/1820"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,1]]},"references-count":27,"journal-issue":{"issue":"10","published-online":{"date-parts":[[2021,10]]}},"alternative-id":["diagnostics11101820"],"URL":"https:\/\/doi.org\/10.3390\/diagnostics11101820","relation":{},"ISSN":["2075-4418"],"issn-type":[{"value":"2075-4418","type":"electronic"}],"subject":[],"published":{"date-parts":[[2021,10,1]]}}}